In this interview with the Corona Investigative Committee, pharma insider Sasha Latypova—who has more than 25 years of experience in the industry—outlines how the Department of Defense has complete control over the development, manufacturing, and distribution of the COVID-19 "vaccines." Latypova also shows how different batches (or "lots") of the COVID injections vary in deadliness based on VAERS data; becoming more detrimental the more they conform to manufacturer specifications.
